Latest posts by Chacruna.net (see all)
- The 40 Best Books About Shamanism and Plant Medicines - August 14, 2019
- Psychedelic Liberty Summit - August 1, 2019
- Documenting the Rise of Huni Kuin Culture in the Heart of the Amazon - June 17, 2019
Brava Theater Center, 2781 24th St, San Francisco, California
April 25 and 26 2020, 9 am to 6 pm
This Summit will bring together experts from around the world to discuss the legal, cultural, and political issues around the emerging psychedelic renaissance. Efforts to decriminalize or legalize psychedelics have picked up steam around the United States, with Denver recently decriminalizing psilocybin mushrooms and Oakland decriminalizing all natural psychedelics. In addition, advocates in Oregon are planning a statewide ballot initiative to regulate psilocybin in 2020. The topics addressed will include: the process of applying for religious exemptions with the DEA; psilocybin decriminalization initiatives; the right to ameliorate pain and suffering; cognitive liberty; drug use and human rights; ibogaine bills; the upcoming FDA regulation of MDMA and psilocybin; psychedelic harm reduction; licensed health care providers and psychedelic-assisted therapy; the paradoxes of cannabis regulation and NIDA monopoly for research cannabis; conservation of endangered species; human’s relationship to sacred plants and nature; the continuities and discontinuities between recreational, therapeutic and religious use of drugs; the future legal markets; and the commercialization of psychedelics. The Summit aims to discuss the future of psychedelic practices in the US, including decriminalization, legalization, and medicalization. Finally, Chacruna will officially launch the Council for the Protection of Sacred Plants at the Summit. The Council is an initiative of the Chacruna Institute that advocates for the legality of sacred plant medicines among indigenous peoples and non-indigenous communities, encourages legal harm-reduction practices that protect those who use them, educates about conservation of plant species, documents relevant legal and social issues, and consults on legal cases.
Presented by: Chacruna
Community Partners: ERIE, Decriminalize Denver, San Francisco Psychedelic Society, Sacred Garden Community, Psychedelic Support, Psychedelics Today, Instituto RIA, NEIP, Drogas, Política y Cultura Wixárika Research Center, Maloca Internacionale, The California Psilocybin Decriminalization & Research Initiative 2020, Consciousness Hacking, California NORML, Modern Spirit, The Psychedelic Society, Beckley Foundation, Sage Integrative Health, Horizons, Psychedelic Seminars, Transform Drug Policy Foundation, Morning Star Conservancy, Transnational Institute, Source Research Foundation, Nierika, Drug Policy Alliance and Decriminalize Nature Oakland
– 2 Day Full Conference: Super Early Bird – $160
– 2 Day Full Conference: Early Bird – $175
– 1 Day Pass (Saturday or Sunday) – $110
– 2 Day Full Conference Standard – $ 190
– 2 Day Full Conference: Last Minute – $210
– 2 Day Full Conference: Student Discount – $80
– 2 Day Full Conference: Scholarship – Free
Registration & Tickets: Here
Chacruna reserves a selection of scholarship tickets for those with limited financial means. For Psychedelic Liberty Summit, priority is being given to people of color, however everyone is encouraged to apply. If you would like to apply for a scholarship ticket, please send us a brief statement (250 words max) describing your interest in attending the conference and why you should receive a scholarship ticket. We will begin reviewing all applications after the deadline on March 1st and will notify those who have been awarded scholarship tickets on March 15th.
Deadline To Apply: March 1st, 2020
Notification of Award: March 15th, 2020
Please fill your application statement here
Dawn D. Davis – Habitat Loss, Decriminalization, Conservation and Legalization Frameworks of Peyote
The peyote cactus [Lophophora williamsii],which is ingested for its medicinal qualities, has been a conservation concern for peyotists and members of the Native American Church (NAC) since 1976. Since 2009, the International Union for the Conservation of Nature has identified peyote as a vulnerable species across its range within the United States and Mexico. The primary threat to long-term conservation is overharvesting due to increased demands by members of the NAC, in addition to improper harvesting techniques of peyote distributors, and large-scale land conversion. This presentation includes not only an examination of the spatial distribution of peyote as it relates to course scale fragmentation of habitat; it will also discuss the intersection of decriminalization, legalization, and conservation. Inclusion of an Indigenous ecological perspective in these conversations allows for inter-Tribal and community-based conservation, co-management, and enactment of sacred ecology. It is important that peyote, as it relates to a bona fide religion recognized by the Supreme Court of the United States, is acknowledged and afforded respect.
Sean McAllister – Denver Psilocybin Initiative: Update on Implementation and Implication for Future Psychedelic Decriminalization Initiatives
Sean will review the strategy behind the campaign that decriminalized psilocybin mushrooms in the city of Denver. He will discuss the ongoing issues with its implementation, including the impacts of the Denver Psilocybin decriminalization campaign on public safety and health. As a member of the Denver Psilocybin Review Panel, he will assess the Review Panel’s work and recommendations regarding psilocybin policy going forward. Implementation issues consisting of educating police and the City Attorney’s Office on personal possession limits for psilocybin, monitoring arrests, carrying out the Psilocybin Review Panel with City Officials, and public education campaigns around harm reduction and psilocybin will be analyzed. Next, Sean will assess the current status of the Decriminalize California campaign and contrast the various efforts to decriminalize psychedelics around the country. Finally, Sean will discuss the many lessons from cannabis legalization that apply to psychedelic campaigns. In particular, Sean will review the advantages and disadvantages of decriminalization initiatives, and contrast the Denver model with other initiatives.
Kevin Feeney – Peyote as Commodity: An Examination of Market Actors and Access Mechanisms
Access to the peyote cactus, a religious sacrament of the Native American Church (NAC), has been regulated since 1965. However, during the last 40 years, the regulated peyote market has shown signs of decline despite reported growth in NAC membership during the same period. This market decline raises questions about the ecological impacts of harvesting practices, as well as levels of consumption of a very limited natural resource. Protecting access to peyote for NAC religious practices and conserving the viability of natural peyote populations are both important goals; goals that should be addressed simultaneously, if possible. In order to determine whether biological, economic, regulatory, or other factors are responsible for the decline in the regulated peyote trade, Access Theory is used to map the various commodity chains that make up the peyote supply network and to identify the primary factors responsible for reduced access to this sacrament. Avenues for bolstering access deficiencies in the peyote supply network are considered, as well as some possible conservation options.
Brad A. Bartlett – Religious Exercise and Controlled Substances: Navigating the U.S. Legal Framework for Sacramental Use of Psychedelics
There are hundreds of groups using ayahuasca in ceremonial contexts in the United States, and many more exercising a brand of therapeutic and mystical uses of psilocybin, peyote, and Sonora Desert toad serum. They all dream of future legalization and the ability to use psychedelics as a religious sacrament or in the exercise of religious activities without fear of criminal prosecution. However, currently, only a handful of religious adherents have received exemptions to U.S. criminal prohibitions on psychedelics. This presentation will discuss legal mechanisms the U.S. government has in place for such situations; a rather complicated scenario that, as currently constituted, seemingly disfavors religious free exercise. Specifically, the author will focus on the history of religious exercise vis-à-vis controlled substances, current policies of the Drug Enforcement Administration requiring petitioning and registration by religious adherents, and possible reforms to the current legal framework.
Jag Davis – Psychedelics and the War on Drugs: What Can We Learn from Cannabis Legalization and Other Social Justice Movements?
How do we account for the multi-generational, ongoing harms of psychedelic criminalization—and how do we begin to repair those harms? In what ways does the War on Drugs continue to drastically limit the scope of scientific research? What are some of the key limitations of the medical model for psychedelics? Where do efforts to decriminalize psychedelics fit within the broader context of criminal justice and public health reform, especially current campaigns to implement Portugal-style drug decriminalization? How can we best maximize the effectiveness of emerging psychedelics-specific policy reform efforts? What can we learn from cannabis legalization and other recent criminal justice reforms? What are some viable non-commercialized models for legalization, such as Spain’s cooperative social clubs for cannabis? What are the strategic and ethical risks of psychedelics “exceptionalism”? How can we ensure that psychedelics aren’t just profitable and legally accessible for a privileged few; all while poor, black, brown, and indigenous people involved with psychedelics continue to be socioeconomically marginalized and harshly criminalized?
Matthew W. Johnson – The Controlled Substances Act, and the Path of Medical Psilocybin Approval
Ongoing research suggests the potential safety and efficacy of psilocybin for several psychiatric disorders. If Phase III research shows safety and efficacy for one of these disorders, this will prompt the potential movement of psilocybin away from its current placement in Schedule I, which is the most restrictive classification and allows for no medical use. This talk will review the 8 factors that inform scheduling decisions under the US Controlled Substances Act (CSA). The talk will review empirical research on psilocybin relevant to each of these 8 factors. This review generally concludes that psilocybin has limited abuse liability. While its use sometimes results in identified harms, the prevalence of harms is considerably lower than for many other scheduled and legal substances of abuse. Moreover, evidence suggests use rates are typically low, and that psilocybin lacks a classic addiction profile. The data suggests that if psilocybin is approved for medical use based on Phase III research, its appropriate placement would be in Schedule IV of the CSA. However, additional safeguards should be provided by the FDA’s framework of Risk Evaluation and Mitigation Strategies (REMS), including the need to use under professional supervision rather than take-home use. Importantly, these recommendations are relevant to medical development of psilocybin under the current CSA framework, notwithstanding the empirically demonstrated civil rights problems and public health harms associated with a criminal system approach to addressing drug harms.
Kufikiri Imara – Decriminalization in Oakland: A One Year Retrospective on Outreach, Education, & Access
This presentation will speak to the experiences of a local, grassroots collective in Oakland that managed to pass the June 4th 2019 resolution to decriminalize access to working with entheogenic plants and is influencing the course of drug decriminalization efforts in different cities across the country. The benefits that decriminalization offers of a shorter, cheaper, and more accessible path to working with entheogenic plants will be highlighted in his presentation. Next, he will provide a snapshot of the current status, ongoing progress, and challenges in Oakland following the city council’s unanimous vote of approval. A few of the central topics to the movement will be presented, such as: What are the impacts of the resolution language? What are the intentions and specific actions emerging from Oakland City Council and the Decriminalize Nature Oakland group? What is the mandate of Decriminalize Nature Oakland’s “Outreach, Education and Access” committee? What are some specific recent and next actions coming from Oakland in this area? What challenges have emerged and how are they being addressed? How can you get involved? This will be a great opportunity to learn from Decriminalize Nature Oakland’s experience at the heart of this transformative decriminalization and educational movement.
Break out sessions
Session 1, facilitated by Ariel Clark and Dale Gieringer: What lessons can psychedelic advocates learn from cannabis regulations and industry?
Session 2, facilitated by Bob Otis Stanley, Dawn D. Davis, Diana Negrín and Anya Ermakova: How can we ensure safe, ethical, inclusive and sustainable sourcing for psychedelic plants and materials?
Session 3, facilitated by Nicolle Greenheart, Sonya Faber and Monnica Williams: How can we strengthen the role of people of color in psychedelic advocacy?
Session 4, facilitated by Ben Meeus and TBA: How can we advance advocacy for plant medicines in the UN?
Session 5, facilitated by Robert Heffernan and J. Hamilton Hudson: Should groups petition the DEA for a Religious Exemption for Psychedelics?
Initial Speakers Line up:
Brad Bartlett is an attorney in Denver, Colorado where serves as senior counsel and director of the Tribal Cannabis Law Group at one of the largest cannabis law firms in the nation. Brad works with tribal nations across the U.S. and Canada on development of tribally owned enterprises related to Cannabis sativa L. Brad previously served as an assistant professor at the University of Denver Sturm School of Law in the Environmental and Natural Resources Law Program. Over his extensive career, Brad has worked with impacted tribal communities, including Native American Church members, on a wide variety of complex tribal and environmental justice matters. Brad is also a seasoned litigator and has brought numerous cases in the public interest addressing government accountability and overreach. Brad graduated the University of Colorado School of Law’s environmental and American Indian Law program in 1998 and is an enrolled tribal member of the Sault Ste. Marie Band of Chippewa Indians of Michigan. Brad is a member of Chacruna’s Council for the Protection of Sacred Plants, where he hopes to advance the dialogue around Controlled Substances Act prohibitions on psychoactive plants and its intersection with state’s rights and religious and medical freedoms.
Ariel Clark is a founding partner of Clark Neubert LLP, a women-owned and run law firm focused on the cannabis and hemp industries. The firm represents established and emerging cannabis businesses across the supply chain and provides advice on corporate governance, financing, business transactional matters, entity formation and operation, and local and state permitting and regulatory compliance. She has served in leadership in a variety of drug policy reform and cannabis and hemp business organizations including the Los Angeles Cannabis Task Force, Cannabis Business Council of Santa Barbara County, California Native American Cannabis Association, California Grower’s Association, and California NORML. Ariel has received many kind distinctions; she was named by Rolling Stone as one of 18 “women shaping the culture of tomorrow,” as one of the top 75 “most important women in cannabis” by Cannabis Business Executive, 30 “most powerful litigators” by MG Magazine, by National Law Journal with a Trailblazer award, and was included in Entrepreneur’s “top 100 cannabis leaders” in 2018. Ariel is very honored to be a member of Chacruna’s Council for the Protection of Sacred Plants
Jag Davies is a political and communications consultant with over 15 years of professional experience advocating for proven health-centered drug policies, harm reduction-based drug education, responsible and equitable legal regulation of cannabis, and extensively reducing the role of criminalization in drug policy. Jag served as Director of Communications Strategy and in other positions at the Drug Policy Alliance from 2009-2019, where he oversaw the organization’s publications, media content, messaging research, and brand identity. Jag also previously served as Policy Researcher for the American Civil Liberties Union (ACLU) Drug Law Reform Project from 2007-2009, and as Director of Communications and in other positions at the Multidisciplinary Association for Psychedelic Studies (MAPS) from 2003-2007. He is regularly quoted in a wide range of media outlets and his writings have appeared in the New York Times, Washington Post, New York Daily News, The Hill, STAT,HuffPost, CNN.com, and dozens of other publications. Jag grew up in Miami and currently lives in New York City.
Dawn D. Davis is a mother, a wife, and a PhD student at the University of Idaho in the Natural Resources program. Her current research uses GIS as one tool to analyze the environmental and anthropogenic issues that surround the revered peyote (Lophophora williamsii) plant, which is integral to her spiritual practice as a Shoshone-Bannock Tribal woman. She is a twice awarded National Science Foundation recipient as a fellow under the Integrative Graduate Education Research Traineeship and as an Indigenous Science Technology Engineering and Math scholar. Dawn has shared her research among Native American, academic, ethnobotanical, and psychedelic audiences nationally and internationally.
Amy Emerson is the Executive Director and Head of Clinical Development and Regulatory Affairs at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit. As the Executive Director, Amy has lead the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC. Amy started as a pro bono consultant at MAPS in 2003, and since then has built MAPS’ clinical department while managing the MDMA Clinical Development Program with a focus on the PTSD indication. In 2014, MAPS Public Benefit Corporation was incorporated to focus on psychedelic drug development, therapist training programs, and future sales of prescription psychedelics prioritizing public benefit above profit. Amy brings decades of pharmaceutical development and research experience in Phase 1 through Phase 3 Randomized Controlled Trials including supporting three successful regulatory approvals for new biologics. Her professional experience at Novartis, Chiron and other pharmaceutical companies (1993-2009) spans various fields including immunology, oncology and vaccines. Pursuing her love of science and nature cultivated while growing up in the woods of Alaska she earned her B.S. in genetics and cell biology from Washington State University in 1992 to prepare for a career in research. Amy is passionate about being a mother and the work of bringing the potential of psychedelics for healing further into the consciousness of the world, leaving a better world for the following generations. She has a lifelong love of travel, living abroad with her husband, exploring in nature and cooking with her family.
Anya Ermakova has a motley background and broad research interests combining nature conservation, ethnobotany, neuroscience and psychiatry, interweaving and connecting these diverse paths through psychedelic science. Anya worked at the forefront of psychedelic research as a science officer at the Beckley Foundation, and has provided psychedelic welfare and harm reduction services with PsycareUK and Zendo.Deep love for nature and wildlife has motivated Anya to study biology at the University of Edinburgh, while a quest to understand altered states of consciousness has prompted her to specialise in neuroscience and later continued during her PhD in psychiatry at Cambridge, where she investigated the origins of psychosis. She then worked for the NHS, developing and trialing a new psychosocial intervention for psychosis. After a brief stint as a clinical trial manager, she had decided to pursue her passion for nature, by studying Conservation Science at Imperial College London, where she is currently studying peyote conservation in Texas.
Dr. Sonya Faber graduated with a Masters in Neurobiology from Brown University after completing her undergraduate work at the University of Pennsylvania. She continued her graduate studies at New York University earning a PhD in molecular genetics with a thesis concentration in signal transduction. Over the course of the last 15 years, she has had the opportunity and privilege to contribute equally to both academic research institutes and commercial pharmaceutical development. She has worked in clinical operations for companies including, IQVIA, Covance and Sanofi-Aventis. Her interests lie in in creating innovative solutions for projects which could benefit both patients and the scientific community, in part by connecting with top scientists, industry and regulatory agencies.In her academic roles, she assessed novel ideas and supported scientists in making these commercially viable while contributing to several original grants and research papers and patents. Her interest in protocol design, medical writing and project management, which she utilized in both pharma and biotech firms, included pre-clinical and clinical activities for phase II and III trials across multiple indications. She has a special interest in training the next generation of clinical researchers and has designed courses to teaching scientific writing and Good Clinical Practice.Dr. Faber is is Associate Director of the Chacruna Institute for Psychedelic Plant Medicines.Her engagement on thisBoard is on a volunteer basis and is based on her personal interest in the science of psychedelics, which has long been an interest of hers before taking her current position at Syneos Health.
Dale Gieringer has been the state coordinator of California NORML (National Organization for the Reform of Marijuana Laws) since 1987. He is also a member of the national NORML board of directors, and director of the Drug Policy Forum of California (DPFCA). Dr. Gieringer was one of the original co-authors of California’s medical marijuana initiative, Prop. 215, and the proponent of Oakland’s Measure Z cannabis initiative in 2004. He has published research on medical marijuana usage, marijuana smoke harm reduction, potency testing, marijuana and driving safety, and drug urinalysis, and has testified before the legislature and in court on issues concerning personal use of marijuana. He also co-sponsored a psychedelic summit to celebrate the 50th anniversary of LSD in 1993, with MAPS and Cal NORML.
Nicolle Greenheart is a co-founder and Board Member of Decriminalize Nature (DN), a nonprofit organization whose mission is to improve human health and well-being by decriminalizing and expanding access to entheogenic plants and fungi through political and community organizing, education and advocacy. As a leading member of the Community Outreach, Education and Access Committee for Decriminalize Nature Oakland (DNO), Nicolle is working to destigmatize psychedelics in the black community and see that safe and equitable access is available to marginalized communities who have suffered most due to systemic oppression, inequality, and the war on drugs. When Nicolle isn’t doing advocacy work, she is learning and growing in the spiritual arts as a Spiritual Alchemist and a curious explorer of energy healing, mysticism and magic. She is passionate about holistic and alternative healing tools and practices, including Reiki, meditation, tarot, chakra balancing, crystal healing, aromatherapy and herbalism. Everything Nicolle involves herself in is an act of radical healing, awakening, transformation and self-love. Besides being a homeschooling mom of two, a Certified Reiki Practitioner, and a writer, she is also a student of astro-numerology, Hawaiian shamanism and sacred entheogenic medicines, practices and traditions. As someone with a deep desire and calling to hold space for and support others on their healing journeys Nicolle is especially committed to doing her own ongoing healing work and considers herself a life-long free-spirited cultivator of her life, a non-conformist to the status quo, and a seeker of truth and wisdom. Ultimately, her mission is for her life to be her message.
Dr. Victoria Hale is a pharmaceutical scientist/executive and global health social entrepreneur. She is a member of the Board of Directors of MAPS. She served as founder & CEO of two successful nonprofit pharmaceutical companies, OneWorld Health (2000) and Medicines360 (2009). OneWorld Health was the first nonprofit pharmaceutical company in the US, focused on leishmaniasis, malaria and cholera; Meds360 developed a hormonal IUD for contraception. She has raised $230M in philanthropic funding, primarily from the Bill & Melinda Gates Foundation. She has partnered with global pharmaceutical companies for drug discovery, manufacturing and commercialization of global health products. She is a MacArthur Fellow, was inducted into the US National Academy of Medicine, has been recognized as an outstanding global social entrepreneur by Skoll, Ashoka and Schwab Foundations. Her drug development experience was obtained at the FDA and Genentech, Inc. She earned her PhD in Pharmaceutical Chemistry from UCSF and is presently Adjunct Professor of Bioengineering and Experimental Therapeutics at UCSF. She lives in San Francisco and has raised two 20-somethings.
J. Hamilton Hudson is an attorney in the U.S. practicing in blockchain and psychedelics. He was born and raised in Hong Kong and lives in Chicago. He earned his JD with an MS in international development from Tulane University in New Orleans and his BA magna cum laude in anthropology from the University of Colorado, Boulder. He is a Research Associate at the Interdisciplinary Group for Psychoactive Studies (NEIP), Brazil/USA and a member of Chacruna’s Council for the Protection of Sacred Plants.
Kufikiri Hiari Imara was born and raised in Oakland, California. He grew up in an Oakland very different than the one we see today, it was an Oakland with a broader and more embodied sense of community. He grew up the youngest in a household with parents who are both Bay Area natives, both of them born in San Francisco. As well, both his parents growing up were active in the Civil Rights and Black Power Movements of a San Francisco of the 1960’s & 70’s. So he grew up in a home and a community environment that strongly emphasized social awareness and social responsibility. Play that forward to an older, wiser individual who unfolded his path through a love of the arts, and his own personal healing/spiritual journey. That path lead him to volunteer work with Green Earth Poets Society bringing poetry to incarcerated African-American youth. He is one of the early members of the Entheogen Integration Circle, a support group in NYC with a focus on marginalized communities within the psychedelic community. He is currently involved with the Sacred Garden Community’s facilitators workshop to deepen his work as a ceremonial facilitator working with ethnically diverse communities. One of the reasons why he got involved with the Decriminalize Nature Oakland (DNO) initiative, is access. And as head of the DNO committee focused on Outreach, Education, & Access, he wants to see broad access when it comes to the opportunity to profoundly change one’s life for the better through working with entheogens. Paying special attention to Oakland’s ethnically diverse and marginalized communities, hes is actively working with individuals and organizations doing the work in these communities for a better tomorrow. He is staying actively engaged with the offices of Oakland city council members to see a better Oakland for all. Access has always been his message and was the focus of his talk when Ihe spoke at the CIIS/Chacruna Symposium Cultural and Political Perspectives on Psychedelic Science, August 2018 in San Francisco. As well as his talk hosted by the San Francisco Psychedelic Society, March 2019. He continues to work towards accessible choices for ethnically diverse and marginalized communities in their ability heal themselves.
Matthew W. Johnson, Ph.D., Associate Professor at Johns Hopkins, is an expert on psychedelics, other drugs, and addiction. Working with psychedelics for >15 years, he has published >100 papers with 47 on psychedelics. Matt published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. He published the first research on psychedelic treatment of tobacco addiction in 2014, and the largest study of psilocybin in treating cancer distress in 2016. His recent psilocybin review recommended placement in Schedule-IV upon medical approval. He has personally guided >100 psychedelic sessions. Matt also conducts behavioral economic research on both addiction and sexual risk. He has published studies on nearly all psychoactive drugs classes, and is President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association. Matt has been interviewed by the New York Times, Washington Post, Wall Street Journal, BBC, CNN, Fox Business News, NPR, CBS News, and NBC News.
Dr. Beatriz Caiuby Labate (Bia Labate) is a queer Brazilian anthropologist who immigrated to the U.S. in 2017. She has a Ph.D. in social anthropology from the State University of Campinas (UNICAMP), Brazil. Her main areas of interest are the study of plant medicines, drug policy, shamanism, ritual, and religion. She is Executive Director of the Chacruna Institute for Psychedelic Plant Medicines (https://chacruna.net), an organization that provides public education about psychedelic plant medicines and promotes a bridge between the ceremonial use of sacred plants and psychedelic science. She is Adjunct Faculty at the East-West Psychology Program at the California Institute of Integral Studies (CIIS) in San Francisco, and Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara. She is also Public Education and Culture Specialist at the Multidisciplinary Association for Psychedelic Studies (MAPS). She is co-founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil, and editor of NEIP’s website (http://www.neip.info), as well as editor of the Mexican blog Drugs, Politics, and Culture (http://drogaspoliticacultura.net). She is author, co-author, and co-editor of twenty books, one special-edition journal, and several peer-reviewed articles (http://bialabate.net).
Mike Margolies is Founder of Psychedelic Seminars (psychsems.com), a conversation-focused event series deepening awareness of the benefits, risks, and complexities of psychedelics. Mike is a community builder who has sparked and mentored Psychedelic Society groups around the world from Baltimore to San Francisco to Portugal. Mike is also Co-Founder of CryptoPsychedelic and former Co-Director of Psymposia.
Sean McAllister is one of nation’s leading drug policy reform lawyers. In 2004, after working for the Colorado Attorney General’s Office for several years, Sean opened a solo law practice focused on criminal defense and represented hundreds of people charged with state and federal drug crimes. That same year, he founded the drug policy reform non-profit Sensible Colorado. Sean served as the chair of the Board of Directors of Sensible Colorado while the organization co-chaired the Colorado recreational marijuana legalization campaign that voters passed in 2012. Sean has also worked on broader drug policy reform issues as a member of the Colorado Commission on Criminal and Juvenile Justice. Today, Sean’s law firm, McAllister Garfield, P.C., has 20 lawyers in four states working primarily on cannabis business law and licensing matters. As part of his work, Sean’s firm has sued regulators numerous times under the administrative procedures act, petitioned the DEA to reconsider a harmful CBD rule, and represented Native America Tribes attempting to participate in the cannabis and hemp industries. In addition to cannabis, Sean has consulted with the Decriminalize Denver campaign, which is the first ballot initiative in the U.S. designed to remove criminal penalties for the possession of psilocybin. Sean is a member of Chacruna’s Council for the Protection of Sacred Plants.
Ben Meeus holds a Master Degree in International and European Law (Cum Laude) from the Free University of Brussels, and a second Master Degree in Latin American Studies at the Centre for Latin American Research and Documentation (CEDLA) in Amsterdam. He has been involved in Santo Daime for 10 years, and wrote a thesis on the legal issues related to the transnationalization of this religious practice. During that same time, he became board member of the Dutch “Centre for the Legal Assessment of the Religious and Ethical Integration of the use of Ayahuasca” (CLAREIA), and volunteered for various human rights causes. After his internship at the “Indigenous Peoples and Minorities Section” of the Office of the United Nations High Commissioner for Human Rights (OHCHR), he became passionate about advancing the rights of indigenous peoples, with a specific interest related to traditional medicinal practices. To that regard, Ben has done extensive voluntary work with and for indigenous representatives in the Brazilian Amazon and abroad. Ben is a member of Chacruna’s Council for the Protection of Sacred Plants.
Diana Negrín is a geographer and educator with a focus on identity, space and social justice movements. She is a native of both Guadalajara, Jalisco and the San Francisco Bay Area, and much of her scholarship and teaching is dedicated to the study of these two regions. Since 2003 she has conducted ethnographic and archival research in the Mexican states of Jalisco and Nayarit with a primary focus on the intersection between historical and contemporary constructions and contestations of race and citizenship. Her current research examines formations and ruptures within interracial and cross-geographic alliances that surround struggles over indigenous territorial and cultural rights. She is the author of Racial Alterity, Wixarika Youth Activism, and the Right to the Mexican City (University of Arizona Press, 2019).
Sara Reed, MS, MFT, is a Marriage and Family Therapist at the Behavioral Wellness Clinic in Tolland, Connecticut and a Study Therapist for the Psilocybin-assisted Psychotherapy for Major Depression initiative at Yale University. A member of the Multidisciplinary Association for Psychedelic Studies (MAPS) Advisory Board, Sara also served as a Sub-Investigator and Study Coordinator for MAPS’ Phase 2 MDMA Clinical Study of Posttraumatic Stress Disorder (PTSD). She is a member of Chacruna’s Racial Equity and Access Committee.
Joseph Rhea is an attorney in Palm Springs, California. Joseph grew up in eastern North Carolina and received his Ph.D. in sociology from Harvard. He taught in the areas of inequality and social movement organization at Harvard and Arizona State University. He is author of Race Pride and the American Identity (2001). As a lawyer, Joseph first represented indigent defendants and then became very involved in cannabis legalization in California. Joseph is a member of Chacruna’s Council for the Protection of Sacred Plants. Joseph is always eager to help with legal issues regarding safe access and he is particularly interested in those projects that address inequalities of access.
Bob Otis Stanley is a co-founder and Board Member of the Decriminalize Nature group responsible for entheogen decriminalization in Oakland CA and is a member of Chacruna’s Council for the Protection of Sacred Plants. He is a long time steward of Oakland’s Sacred Garden Community and leads clinical and molecular informatics projects by day. Bob has enjoyed growing sacred plants and exploring sacred plant traditions independently and under recognized mentorship for over 30 years. Lifetime interest in diverse cultures and wisdom traditions was complemented by his Tennessee family’s medical, religious, and wild-crafting traditions. Family medical and ecological work in Asia, Central and South America exposed Bob to non-Western healing traditions at an early age. Transformative personal and group experiences with sacred plants and materials guide his passion for working with what he considers to be plant sacraments. Following Psychology and Religious studies degrees from University of California Santa Cruz, Bob earned a Masters degree in Divinity from University of Chicago. Post-graduate cognitive science research at New York University led to professional work in epistemology and life science informatics. In addition to sacred plant learning, teaching and conservation through gardening, Bob’s passions include epistemology, bicycling, and playing his Grandma’s violin. Bob is committed to growing respectful access to traditional plant sacraments and to their newly recognized relatives. He recognizes these plants as healing sacraments, properly venerated by ancient, living and emerging syncretic traditions.
Daiara Hori Figueroa Sampaio – Duhigô is a member of of the Tukano indigenous people, the Yé’pá Mahsã, clan, and the Eremiri Hãusiro Parameri of the Alto Rio Negro in the Brazilian Amazon. She was born in São Paulo, Brazil. She is an artist, activist, educator, and communicator. She holds a master’s in human rights from the University of Brasília – UnB, and is a researcher on the right to the memory and truth of indigenous peoples. She is Coordinator of Radio Yandê, the first indigenous web-radio in Brazil: www.radioyande.com. She studies the culture, history, and traditional spirituality of indigenous people and their environment. She currently resides in Brasilia, DF.
Monnica T. Williams is a board-certified licensed clinical psychologist and Associate Professor at the University of Connecticut in the Department of Psychological Sciences and Department of Psychiatry. She is also Clinical Director of the Behavioral Wellness Clinic, where she provides supervision and training to clinicians for empirically-supported treatments. Prior to her move to Connecticut in 2016, Dr. Williams served as the Director of the Center for Mental Health Disparities at the University of Louisville in the Department of Psychological and Brain Sciences. Dr. Williams’ research focuses on African American mental health, culture, and psychopathology, and she has published over 100 scientific articles on these topics. Current projects include the assessment of race-based trauma, unacceptable thoughts in OCD, improving cultural competence in the delivery of mental health care services, and interventions to reduce racism. This includes her work as a PI in a multisite study of MDMA-assisted psychotherapy for PTSD. She also gives diversity trainings nationally for clinical psychology programs, scientific conferences, and community organizations. Dr. Williams is Associate Director of the Chacruna Institute for Psychedelic Plant Medicines.
Sponsorship Opportunities Available
Sponsorship helps Chacruna to make this conference affordable and accessible to the public and ensures a diversity of speakers and voices are heard. We have intentionally kept ticket prices low given the high costs of organizing an event in San Francisco.
Sponsors receive recognition for their support of Psychedelic Liberty Summit at the event, on our social media channels, on our conference website, and in the video recordings of the event.
All sponsorship donations are tax-deductible as a donation through our fiscal sponsor, the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit research and educational organization.
Please email Bia Labate at: email@example.com with inquiries regarding sponsorships.